Medicare Prior Authorization in 2027: What Changed and How Medicare Advantage, Original Medicare and Medigap Differ

Prior authorization means approval may be required before a plan will cover a particular medical item or service.

For Medicare Advantage members, the plan evaluates whether the requested care meets Medicare coverage requirements and any permitted plan criteria before the service is provided.

Prior authorization is different from a referral. A referral generally involves permission or direction to see another provider. Prior authorization involves approval of the actual service, procedure, treatment, equipment or other covered item. A Medicare Advantage plan might therefore allow you to see a specialist while still requiring authorization for something that specialist orders.

Yes. Medicare Advantage plans can use prior authorization for medical services when permitted under Medicare rules. The specific services subject to authorization vary by insurer, plan and service.

That means you should never assume that because one Medicare Advantage plan requires authorization for a particular procedure, every competing plan will have the same rule. Likewise, an insurer reducing prior authorization nationally does not mean it eliminated authorization for every service.

UnitedHealthcare's October 2026 change is a good example. The company says it removed about 30% of prior-authorization requirements — not 100%. Beneficiaries should still verify the requirement for the exact service and exact plan.

One of the biggest federal changes took effect January 1, 2026. CMS now requires Medicare Advantage organizations and certain other affected payers to make decisions on prior-authorization requests for medical items and services other than drugs within 7 calendar days for a standard request and 72 hours for an expedited or urgent request.

CMS emphasizes that plans must act sooner if the patient's medical condition requires a faster decision. These are maximum decision periods — not guaranteed waiting periods, and they do not mean a plan should wait seven days when a decision can reasonably be made sooner.

The CMS deadline is measured in calendar time, not business days. An expedited request received early Sunday still has to meet the 72-hour deadline rather than waiting for the next business day. That distinction can matter when medically necessary care is being scheduled quickly.

Beginning in 2026, CMS requires affected payers, including Medicare Advantage organizations, to provide a specific reason when denying prior authorization for applicable medical items and services. The purpose is to make it easier for the provider to correct missing information, resubmit a request or pursue an appeal.

This requirement does not automatically apply to every prescription-drug prior authorization because drug authorization operates under separate rules. If a medical prior-authorization request is denied, read the actual denial reason. Your provider may be able to determine whether the issue involves missing documentation, a coverage criterion, medical-necessity information, the wrong request pathway, or another correctable problem.

January 1, 2027 is another major date. CMS requires certain health plans, including Medicare Advantage organizations, to implement and maintain electronic application programming interfaces — or APIs — that support prior authorization for medical items and services. The goal is to allow providers and plans to exchange authorization information electronically instead of relying as heavily on phone calls, faxes and separate web portals.

This should not be described as prior authorization becoming instant in 2027. The electronic infrastructure is mandatory for applicable payers, but approval still depends on the coverage criteria and medical documentation involved.

Separate from CMS's binding federal rules, major insurers made a voluntary industry commitment to reform prior authorization. Participants included Aetna, Cigna, Humana, UnitedHealthcare and other large insurers. Among the commitments announced by HHS and CMS were reducing the number of services requiring authorization, honoring existing authorizations during insurance transitions, improving transparency, ensuring clinical denials are reviewed by medical professionals, and expanding real-time responses so that most requests can receive real-time approval by 2027.

That pledge is important. But it should not be confused with a federal guarantee that every Medicare Advantage request will receive instant approval in 2027.

UnitedHealthcare says it eliminated approximately 30% of prior-authorization requirements beginning October 1, 2026. The change applies to several lines of business, including UnitedHealthcare Medicare Advantage plans.

This is meaningful because it can reduce the number of services that require approval. However, beneficiaries should still verify the requirement for the exact service and exact plan. A national insurer announcement is not enough to determine whether your upcoming MRI, infusion, surgery, therapy or piece of medical equipment requires authorization.

Aetna announced on September 17, 2026 that instead of requiring separate prior authorizations for multiple components of cancer treatment, it is expanding bundled authorizations that can include medical oncology, chemotherapy or immunotherapy, radiation oncology and related advanced imaging. Aetna says it expects to expand eligibility to Medicare and commercial members during the first half of 2027.

This is a useful example of where prior authorization may continue to exist but the process itself becomes less fragmented. It does not mean every Aetna Medicare member or every cancer service automatically receives blanket approval. The applicable plan, service and clinical circumstances still matter.

Medicare Advantage beneficiaries receiving ongoing treatment have federal continuity protections. CMS requires a minimum 90-day transition period when someone currently undergoing treatment switches to a new Medicare Advantage plan. During that transition, the new plan may not require new prior authorization for the active course of treatment.

CMS also requires an approved authorization for a course of treatment to remain valid for as long as medically reasonable and necessary under the applicable coverage criteria, the patient's history and the treating provider's recommendation. This protection is especially important for people undergoing cancer treatment, rehabilitation, infusion therapy, complex specialty care, or another continuing course of treatment.

A denial is not necessarily the end of the process. Medicare beneficiaries have appeal rights. For a Medicare Advantage medical-service denial, Medicare says you, your representative, or your provider generally have 65 days from the date of the initial denial notice to file the appeal. Your provider can strengthen the appeal with clinical records, medical-necessity documentation or other supporting information.

The initial prior-authorization decision generally has a 7-calendar-day standard deadline or 72-hour expedited deadline for applicable medical requests. But once a Medicare Advantage denial is appealed, the appeal has its own timeline. A standard pre-service appeal generally must be decided within 30 days. A fast appeal generally must be decided within 72 hours when waiting for the standard process could seriously jeopardize the beneficiary's life, health or ability to regain maximum function.

If the Medicare Advantage plan upholds the denial in whole or in part at the first appeal level, Medicare says the case is automatically forwarded to an independent review entity for Level 2 review. An analysis by KFF using CMS Medicare Advantage reporting data found that about 4.1 million prior-authorization requests were fully or partially denied in 2024. Only about 11.5% of denials were appealed, but approximately 80.7% of the appealed denials were partially or fully overturned.

Sometimes. Original Medicare uses prior authorization far less broadly than Medicare Advantage, but saying it never requires prior authorization is inaccurate. CMS operates targeted prior-authorization and pre-payment-review programs for certain medical equipment, outpatient services and other categories.

KFF's analysis of CMS data found nearly 53 million Medicare Advantage prior-authorization determinations in 2024, compared with just over 625,000 Original Medicare prior-authorization reviews. That works out to roughly 1.7 requests per Medicare Advantage enrollee versus about 2 reviews per 100 Original Medicare beneficiaries. Those numbers show that utilization management is much more extensively used in Medicare Advantage — but they should not be used to claim Original Medicare has no authorization requirements.

CMS has added new items to its required DMEPOS prior-authorization list. Beginning October 28, 2026, prior authorization becomes a condition of payment nationwide for several newly selected categories, including certain orthoses, a pressure-reducing support surface and a manual wheelchair base.

Two additional upper-limb orthosis codes are being introduced in phases. The first phase starts October 28 in California, Florida, Michigan and New York. The second phase begins January 26, 2027 and expands to additional states including Georgia, Ohio, Pennsylvania and Texas. The third phase begins April 26, 2027 and expands nationwide. That makes this issue particularly relevant in several states where The Medicare Dude is licensed.

CMS's Wasteful and Inappropriate Service Reduction — or WISeR — Model is another targeted Original Medicare review program. It operates in six states: Arizona, New Jersey, Ohio, Oklahoma, Texas and Washington. Among The Medicare Dude's licensed states, Ohio and Texas are affected.

WISeR applies only to selected items and services considered vulnerable to inappropriate use, fraud or waste. CMS says providers in those states can either submit a prior-authorization request for an included service or furnish the service and have the claim undergo pre-payment medical review. Importantly, CMS says WISeR does not apply to people enrolled in Medicare Advantage.

A Medicare Supplement — or Medigap — policy works differently from Medicare Advantage. Medigap supplements Original Medicare rather than replacing it. Medicare.gov explains that Medicare first determines and pays its share of the Medicare-approved amount for a covered service. The Medigap policy then pays its applicable share under the policy.

That means a Medigap insurer generally does not operate a separate Medicare Advantage-style medical-management process deciding whether Original Medicare-covered care is authorized. But Medigap also cannot make Medicare cover something that Original Medicare does not cover.

A more accurate statement is: Medigap itself generally does not add a separate prior-authorization layer, but the underlying Original Medicare coverage and review rules still apply.

Prior authorization should not be the only reason someone chooses one form of Medicare coverage over another. Medicare Advantage may offer lower or $0 additional premiums, bundled prescription coverage, supplemental benefits, and an annual maximum out-of-pocket limit for covered Part A and Part B services. Original Medicare with Medigap may offer broader provider access, fewer plan-level utilization-management requirements, standardized Medigap benefits, and more predictable medical cost sharing depending on the Medigap plan.

The right choice depends on your doctors, prescriptions, budget, travel, health-care utilization and eligibility to obtain Medigap.

This distinction is critical for someone frustrated with Medicare Advantage prior authorization. Medicare Open Enrollment runs October 15 through December 7. You can use that period to leave Medicare Advantage and return to Original Medicare.

But doing so does not automatically create a nationwide guaranteed right to purchase Medigap. Outside your federal Medigap Open Enrollment Period, your ability to obtain a Medicare Supplement policy may depend on a federal guaranteed-issue right, trial right, state protection or medical underwriting. Do not disenroll from Medicare Advantage solely because of prior-authorization frustration while assuming a Medigap carrier must accept you. Verify your eligibility first.